So we're seeing a lot of innovations like this. What I'm worried about is innovation in vaccine science. I work on the venture capital side where we make investments in new companies. And There has been a pullback of biotech startups that have been looking to develop new vaccines. For example, vaccines for Epstein Barr virus, which we know is linked to certain B cell lymphomas and maybe is linked to multiple sclerosis. That's a new area of science. (08:20–08:26)
CLAIM
Asserts that biotech startups are reducing efforts to develop new vaccines.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
